US Stock MarketDetailed Quotes
BPTH Bio-Path Holdings
- 1.260
- -0.230-15.44%
Close Dec 20 16:00 ET
- 1.180
- -0.080-6.35%
Post 20:01 ET
5.43MMarket Cap-0.15P/E (TTM)
1.450High1.160Low3.79MVolume1.390Open1.490Pre Close4.75MTurnover96.87%Turnover RatioLossP/E (Static)4.31MShares12.00052wk High-7.64P/B4.93MFloat Cap0.59352wk Low--Dividend TTM3.92MShs Float23999.988Historical High--Div YieldTTM19.46%Amplitude0.593Historical Low1.251Avg Price1Lot Size
About Bio-Path Holdings Company
Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1001-A, BP1002, and BP1003. The company was founded by Peter H. Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.
Company Profile
SymbolBPTH
Company NameBio-Path Holdings
Listing DateMar 10, 2014
Issue Price0.50
Founded2007
CEOMr. Peter H. Nielsen
MarketNASDAQ
Employees10
Fiscal Year Ends12-31
Address4710 Bellaire Boulevard,Suite 210
CityBellaire
ProvinceTexas
CountryUnited States of America
Zip Code77401
Phone1-832-742-1357
Company Executives
- Name
- Position
- Salary
- Peter H. Nielsen
- Chairman of the Board, Chief Executive Officer, President, Principal Accounting Officer, Chief Financial Officer and Treasurer
- 827.12K
- Douglas P. Morris
- Director, Secretary and Director, Investor Relations
- 89.98K
- Heath W. Cleaver, C.P.A.
- Independent Director
- 85.31K
- Paul D. Aubert
- Independent Director
- 73.81K
- Aline B. Sherwood
- Independent Director
- 76.81K
Heat List
US
Overall
Symbol
Price
% Chg
No Data